After several cycles of lab testing on test animals, a medication can enter clinical trials for evaluation in humans. In phase II clinical trial testing:
A) the trial is expanded to include a large sample size, usually in the thousands of individuals, and establish the overall safety and effectiveness of the drug.
B) the medication is compared to other medications on the market.
C) consists of the drug being tested on a small number (usually 300 or less) of people with the illness or condition the drug is designed to treat.
D) researchers attempt to determine the safe dose and how the medication is both absorbed and eliminated from the body.
Answer: C
You might also like to view...
You are examining a 48-year-old patient who has been burned. You decide to use the rule of palm to measure the extent of the burn. What does this mean?
A) The palm of the patient's hand equals about 1% of the body's surface area. B) The palm of your hand represents 1% of the body's surface area. C) You can only use the rule of palm for children, so you would use the rule of nines instead. D) The palm of the patient's hand equals 9% of the body's surface area.
Acetylcholine stimulates M3 receptors on airway smooth muscle, causing which of the following?
a. Bronchodilation b. Bronchoconstriction c. Decrease in mucous gland secretion d. There are no M3 receptors in the airway.